Differential alteration of IL-8 in liver cancer stem cell enrichment in response to PI3K/Akt/mTOR inhibitors and sorafenib
D. C. Kahraman, T. Kahraman, R. Cetin-Atalay
The paper investigates how PI3K/Akt/mTOR inhibitors and Sorafenib affect liver cancer stem cell (LCSC) populations and identifies IL-8 as a key regulator of stemness.
bioRxiv · Apr 25, 2018Cancer Biology